| Antiviral | EC50 ratio | Phenotype | Strain | Source | Marker | Assay | Reference |
|---|---|---|---|---|---|---|---|
| Letermovir | 52.00 | High level resistance | Clinical Isolate | Details | Letermovir Resistance Analysis in a Clinical Trial of Cytomegalovirus Prophylaxis for Hematopoietic Stem Cell Transplant Recipients. (Mar 2020) |
| Mutant | Resistances |
|---|---|
| R369G |
Letermovir:
|
| R369K |
Letermovir:
|
| R369M |
Letermovir:
|
| R369S |
Letermovir:
|